Weak R&D and IP Infrastructure in India May Impede Government’s Biotech Leadership Ambitions
India plans to invest in domestic pharmaceutical research and manufacturing to become a global biotechnology leader by 2030. However, weak IP protection could hinder growth. Efforts include a new Biotechnology Research Innovation and Entrepreneurship Development (BIO-Ride) scheme, the National Biotech Strategy 2021-2025, and collaborations with industry players like Merck Life Science. Challenges include the need […]